From R&D Investment to Externalization: Where is the Pharma Industry Maximizing Value?

Overview Pharmaceutical companies are attempting to maximize value from all angles, including internal investment in R&D and externalization via deal-making. The growth in these two models has had an impact on both revenue derived from internally developed products, as well as externalized drugs. This report is a written adaptation of a webinar presented in May …

The Corporate Reputation of Pharma Industry – The Patient Perspective in 2015 – Nordic Edition

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 147 Nordic patient groups in 2015, focusing on differing medical specialties. The report provides feedback on the corporate reputation of the Nordic pharma industry during 2015, as well as the performance of 20 pharma companies for six key …

The Corporate Reputation of Pharma Industry – The Patient Perspective in 2015 – Eastern Europe Edition

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 93 patient groups in 2015, focusing on differing medical specialties. The report provides feedback on the corporate reputation of the Eastern-European pharma industry during 2015, as well as the performance of 19 pharma companies for six key indicators …

Managing Vendor/CRO/CMO Oversight in the Pharma Industry (London, United Kingdom – March 20-21, 2018)

Learn how to prepare a Request for Proposal (RFP), evaluate and select the right CRO and establish procedures for vendor oversight for R&D projects you need to outsource. This workshop is specifically designed for sponsoring pharma companies who are outsourcing critical practices to improve productivity. It will help you get to grips with effective CROs/Vendors …

Effective Training Skills and Processes in the Pharma Industry (London, United Kingdom – June 4-5, 2018)

An interactive course ideal for anyone with responsibility for planning or delivering training in the pharma, device or animal health industries (including GxP and SOP training to comply with EU and FDA inspection requirements) Training can play an important role in the  success of a company and in employee performance, with effective training and support …

Managing Vendor/CRO/CMO Oversight in the Pharma Industry (London, United Kingdom – October 4-5, 2018)

Learn how to prepare a Request for Proposal (RFP), evaluate and select the right CRO and establish procedures for vendor oversight for R&D projects you need to outsource. This workshop is specifically designed for sponsoring pharma companies who are outsourcing critical practices to improve productivity. It will help you get to grips with effective CROs/Vendors …

Benchmarking the Pharma Industry’s HEOR Functions

This report provides pharmaceutical and biotech organizations an opportunity to benchmark their own Health Economics and Outcomes Research (HEOR) approaches against that of Top 50 Pharma companies. The report details best practices, common approaches, as well as explains alternative styles so companies can use these assessments as a yard stick against which to measure, modify, …

Benchmarking the Pharma Industry’s Medical Affairs Functions

Medical Affairs, as a function, sits at a crossroads in the pharmaceutical industry. The department isexpected to act as a bridge between the commercial and scientific arms of an organization. Medical Affairs is further tasked with being the conduit of information between the company and external stakeholders, bringing efficacy and safety data to the medical …